1. Home
  2. ENVA vs VRDN Comparison

ENVA vs VRDN Comparison

Compare ENVA & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$162.07

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$33.29

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
VRDN
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ENVA
VRDN
Price
$162.07
$33.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
12
Target Price
$155.40
$39.73
AVG Volume (30 Days)
234.5K
1.6M
Earning Date
02-03-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
73.62
N/A
EPS
10.82
N/A
Revenue
$1,414,115,000.00
$70,789,000.00
Revenue This Year
$159.72
$26,477.48
Revenue Next Year
$16.16
$6.23
P/E Ratio
$15.04
N/A
Revenue Growth
20.78
23340.07
52 Week Low
$79.41
$9.90
52 Week High
$164.42
$33.34

Technical Indicators

Market Signals
Indicator
ENVA
VRDN
Relative Strength Index (RSI) 85.55 67.61
Support Level $134.00 $32.29
Resistance Level $132.15 $33.29
Average True Range (ATR) 4.46 1.19
MACD 3.16 -0.15
Stochastic Oscillator 89.85 79.58

Price Performance

Historical Comparison
ENVA
VRDN

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: